—Long-acting bronchodilators are recommended for initial maintenance of COPD. A new study compares the cardiovascular safety of 2 common treatment options. Reviewed by Ware Kuschner, MD, Professor of ...

Study results show that patients with chronic obstructive pulmonary disease (COPD) and comorbid asthma may have a greater risk of hospitalization from COVID-19 if they use bronchodilators or steroids ...

A review gives an overview of potential biomarkers in chronic obstructive pulmonary disease. In a recently published review, researchers outlined the background research and results of clinical trials ...

Treatment of asthma can be divided into two therapeutic strategies, intervention measures for acute symptoms ( Table 2) and maintenance measures for prevention of future symptoms ( Table 3). The most ...

Lung disease experts at Johns Hopkins are calling for physicians to show much greater caution in prescribing inhaled corticosteroid drugs for people with chronic obstructive pulmonary disease after ...

Among 535 symptomatic smokers with a 10 pack-year history and preserved lung function assessed by spirometry, 56.4% in the treatment group and 59.0% in the placebo group had a least a 4-point decrease ...

Please provide your email address to receive an email when new articles are posted on . The meta-analysis included 27 unique randomized controlled trials and 50,496 patients. Combinations improved ...

Please provide your email address to receive an email when new articles are posted on . Bronchodilator responsiveness over 20% was linked to exacerbations and decreased prebronchodilator FEV 1. More ...

Predetermined entry criteria allowed inclusion of only those children who: (1) had no family history of asthma; (2) had no personal or family history of atopic disease; (3) had been receiving ...